Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment

NCT03292900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 758

Last updated 2019-02-15

No results posted yet for this study

Summary

To assess the effectiveness of the use of a patient's genes to predict which hypertension therapy is successful

Conditions

Sponsors & Collaborators

  • Fairview Health Services

    collaborator OTHER
  • Geneticure, LLC

    lead INDUSTRY

Principal Investigators

  • Pamela Phelps, PharmD · Fairview Health System

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-12-15
Completion
2019-01-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03292900 on ClinicalTrials.gov